Search Results

University Lab Partners (ULP) is thrilled to announce the return of the Golden Ticket pitch competition for aesthetic startups, proudly sponsored by Allergan Aesthetics, an AbbVie Company.

Golden Biotechnology Corp. had unveiled the findings of its Phase II clinical trial investigating Antroquinonol in combination with the standard of care: nab-paclitaxel + gemcitabine, as first-line treatment for metastatic pancreatic cancer.

Golden Helix, Inc. announced that it was awarded the NIH SBIR Grant 1R43HG013456-01 “Pharmacogenomics Workflow: Identifying Biomarkers and Treatment Options.”.

Golden State Medical Supply, a leading provider of generic pharmaceuticals to the US Federal Government and Finarb Analytics Consulting, a consult-to-operate data and AI solutions provider, have announced a strategic partnership to develop an AI enabled demand forecasting model to accurately estimate demand across all client facilities of GSMS.

Vir Biotechnology, Inc. (Nasdaq: VIR) today provided a corporate update and reported financial results for the first quarter ended March 31, 2024.

CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products based on its non-animal-derived collagen for tissue regeneration and medical aesthetics, today announced results for the first quarter ended 2024 and provided a corporate update.

Leading global biotechnology company Amgen and NSG BioLabs, Singapore’s largest and leading provider of biotechnology co-working laboratories and offices, announced Albatroz Therapeutics as the winner of the first Amgen Golden Ticket in Singapore.